This is to inform you that the Board of Directors of the Company at their meeting held today i.e. 14th November, 2025 have approved and adopted the Un-audited Financial Results of the Company ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemiesynth (Vapi) Ltd's Board, at its meeting on 14 November 2025, approved the unaudited financial results for the quarter and half year ended 30 September 2025. Revenue from operations for Q2 FY26 stood at Rs. 687.15 lakhs, up roughly 73% from Rs. 397.46 lakhs in Q2 FY25. For the half year, revenue rose about 30% to Rs. 1,084.61 lakhs versus Rs. 832.22 lakhs a year ago. Despite the strong top-line growth, the company slipped into a loss of Rs. 43.95 lakhs in Q2 FY26 and Rs. 61.41 lakhs for H1 FY26. The statutory auditor Manoj Shah & Co. issued a clean Limited Review Report with no qualifications.
Strong revenue growth is a positive sign, but persistent losses suggest margin pressure and limited near-term earnings visibility. Shareholders should track whether the topline momentum eventually translates into profitability, as continued losses could weigh on the stock despite revenue expansion.